Hygiene protocols for the treatment of denture-related stomatitis: local and systemic parameters analysis-a randomized, double-blind trial protocol

被引:14
|
作者
Ribeiro, Adriana B. [1 ]
de Araujo, Camila B. [1 ]
Silva, Luiz Eduardo, V [2 ]
Fazan-Junior, Rubens [2 ]
Salgado, Helio C. [2 ]
Ribeiro, Aline B. [2 ]
Fortes, Caroline, V [1 ]
Bueno, Frank L. [1 ]
de Oliveira, Viviane C. [1 ]
Paranhos, Helena de F. O. [1 ]
Watanabe, Evandro [3 ]
Silva-Lovato, Claudia H. [1 ]
机构
[1] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Dent Mat & Prosthodont, Ribeirao Preto, Brazil
[2] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Physiol, Ribeirao Preto, Brazil
[3] Univ Sao Paulo, Sch Dent Ribeirao Preto, Dept Restorat Dent, Ribeirao Preto, Brazil
基金
巴西圣保罗研究基金会;
关键词
Complete dentures; Biofilm; Cleansers; Candida; Stomatitis; Clinical trials; Heart diseases; CLINICAL-TRIAL; T-CELLS; CANDIDIASIS; DISEASE; SALIVA; MUC1;
D O I
10.1186/s13063-019-3854-x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background Denture-related stomatitis (DS) is chronic multifactorial inflammation, strongly related to the presence of the biofilm that is the complex structure formed by microorganisms held together by a mucus-like matrix of carbohydrate that adheres to different surfaces, including the denture surface. DS has recently been correlated with deleterious cardiovascular alterations. The potential effect of hygiene protocols in the control of DS and randomized clinical trials that address this oral condition with cardiovascular complications are important in clinical decision-making. Material/design A clinical trial, randomized, double-blind, and with parallel groups, will be conducted in Brazil The sample will consist of 100 patients without teeth in both arches, users of at least maxillary complete dentures, and diagnosed with DS, who will be allocated to groups (n = 25 per group) according to the different hygiene protocols: (1) brushing of the palate and immersion of the prosthesis in 0.25% sodium hypochlorite solution (positive control); (2) brushing of the palate and immersion of the prosthesis in 0.15% triclosan solution; (3) brushing of the palate and immersion of the prosthesis in lactose monohydrate; or (4) brushing the palate with citric acid and immersing the prosthesis in lactose monohydrate. The response variables will be heart rate variability and alteration of blood pressure (systemic level), remission of DS, removal of biofilm, reduction of microbial load (colony-forming units (CFU)), mouth and prosthesis odor level, expression of MUC1, proinflammatory cytokines, C-reactive protein (CRP), viscosity, pH and salivary flow (locally); patient-centred qualitative analysis will also be undertaken. Measurements will be performed at baseline and 10 days after the interventions. The results obtained will be statistically analyzed as pertinent, with a level of significance of 0.05. Discussion This study will provide a guideline for clinical practice regarding the use of hygiene protocols in the treatment of oral diseases (DS) mediated by biofilm. Also, it may provide evidence of correlation of oral manifestation with cardiac risk.
引用
收藏
页数:10
相关论文
共 50 条
  • [32] Treatment with Creatine Monohydrate in Spinal and Bulbar Muscular Atrophy: Protocol for a Randomized, Double-Blind, Placebo-Controlled Trial
    Hijikata, Yasuhiro
    Katsuno, Masahisa
    Suzuki, Keisuke
    Hashizume, Atsushi
    Araki, Amane
    Yamada, Shinichiro
    Inagaki, Tomonori
    Ito, Daisuke
    Hirakawa, Akihiro
    Kinoshita, Fumie
    Gosho, Masahiko
    Sobue, Gen
    JMIR RESEARCH PROTOCOLS, 2018, 7 (03):
  • [33] Efficacy of Bi Qi Capsules in combination with methotrexate in the treatment of rheumatoid arthritis A protocol of double-blind randomized controlled trial
    Ding, Weizhong
    Chen, Shirong
    Shi, Xuexiang
    Zhao, Yang
    MEDICINE, 2021, 100 (20) : E25790
  • [34] TREATMENT OF ALCOHOL-RELATED LIVER-DISEASE WITH (+)-CYANIDANOL-3 - A RANDOMIZED DOUBLE-BLIND TRIAL
    COLMAN, JC
    MORGAN, MY
    SCHEUER, PJ
    SHERLOCK, S
    GUT, 1980, 21 (11) : 965 - 969
  • [35] Augmenting Outpatient Alcohol Treatment as Usual With Online Alcohol Avoidance Training: Protocol for a Double-Blind Randomized Controlled Trial
    Bratti-van der Werf, Marleen K. J.
    Laurens, Melissa C.
    Postel, Marloes G.
    Pieterse, Marcel E.
    Ben Allouch, Somaya
    Wiers, Reinout W.
    Bohlmeijer, Ernst T.
    Salemink, Elske
    JMIR RESEARCH PROTOCOLS, 2018, 7 (03):
  • [36] Treatment of myofascial pain with a rapid laser therapy protocol compared to occlusal splint: A double-blind, randomized clinical trial
    Maracci, Lucas Machado
    Stasiak, Gabriela
    Chami, Vitoria de Oliveira
    Franciscatto, Gisele Jung
    Milanesi, Jovana
    Figueiro, Claudio
    Bernardon, Tatiana
    Guimaraes, Magali Beck
    Marquezan, Mariana
    CRANIO-THE JOURNAL OF CRANIOMANDIBULAR & SLEEP PRACTICE, 2022, 40 (05): : 433 - 439
  • [37] Belimumab for the Treatment of Early Diffuse Systemic Sclerosis Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial
    Gordon, Jessica K.
    Martyanov, Viktor
    Franks, Jennifer M.
    Bernstein, Elana J.
    Szymonifka, Jackie
    Magro, Cynthia
    Wildman, Horatio F.
    Wood, Tammara A.
    Whitfield, Michael L.
    Spiera, Robert F.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70 (02) : 308 - 316
  • [38] Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis
    Ilowite, Norman T.
    Prather, Kristi
    Lokhnygina, Yuliya
    Schanberg, Laura E.
    Elder, Melissa
    Milojevic, Diana
    Verbsky, James W.
    Spalding, Steven J.
    Kimura, Yukiko
    Imundo, Lisa F.
    Punaro, Marilynn G.
    Sherry, David D.
    Tarvin, Stacey E.
    Zemel, Lawrence S.
    Birmingham, James D.
    Gottlieb, Beth S.
    Miller, Michael L.
    O'Neil, Kathleen
    Ruth, Natasha M.
    Wallace, Carol A.
    Singer, Nora G.
    Sandborg, Christy I.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (09) : 2570 - 2579
  • [39] Multicenter double-blind randomized controlled trial to evaluate the effectiveness and safety of bortezomib as a treatment for refractory systemic lupus erythematosus
    Ishii, Tomonori
    Tanaka, Yoshiya
    Kawakami, Atsushi
    Saito, Kazuyoshi
    Ichinose, Kunihiro
    Fujii, Hiroshi
    Shirota, Yuko
    Shirai, Tsuyoshi
    Fujita, Yoko
    Watanabe, Ryu
    Chiu, Shih-Wei
    Yamaguchi, Takuhiro
    Harigae, Hideo
    MODERN RHEUMATOLOGY, 2018, 28 (06) : 986 - 992
  • [40] Comparison of methotrexate with placebo in the treatment of systemic sclerosis: A 24 week randomized double-blind trial, followed by a 24 week observational trial
    VandenHoogen, FHJ
    Boerbooms, AMT
    Swaak, AJG
    Rasker, JJ
    VanLier, HJJ
    Vandeputte, LBA
    BRITISH JOURNAL OF RHEUMATOLOGY, 1996, 35 (04): : 364 - 372